Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) EBT Margin (2021)

Atea Pharmaceuticals (AVIR) has 1 years of EBT Margin data on record, last reported at 63.08% in Q4 2021.

  • For Q4 2021, EBT Margin changed N/A year-over-year to 63.08%; the TTM value through Sep 2022 reached 18.75%, down 513.0%, while the annual FY2021 figure was 39.44%, 6195.0% up from the prior year.
  • EBT Margin reached 63.08% in Q4 2021 per AVIR's latest filing, up from 67.34% in the prior quarter.
  • Across five years, EBT Margin topped out at 63.08% in Q4 2021 and bottomed at 67.34% in Q3 2021.